Content Experts Wylie Burke, MD, PhD
Professor and Chair, Department of Medical History & Ethics
Adjunct Professor, Medicine; Epidemiology
University of Washington
  
Mary Daly, MD, PhD
Senior Member, Population Science Division
Fox Chase Cancer Center
  
Kathy Helzlsouer, MD, MHS
Professor, Epidemiology & Oncology
Department of Epidemiology
John Hopkins University
  
Monica McClain, PhD
Associate Director, Biometry and Epidemiology
Foundation for Blood Research
  
Mark Robson, MD
Clinical Genetics Service
Memorial Sloan Kettering Cancer Center
  
Stephen Taplin, MD
Applied Research Program
National Cancer Institute
  
Donald Berry, PhD
Professor, Chair
Department of Biostatistics
The University of Texas
MD Anderson Cancer Center

From: Appendix F. Reviewers

Cover of Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [Internet].
Evidence Syntheses, No. 37.
Nelson HD, Huffman LH, Fu R, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.